Most studies actually analyzing genes associated with an increased risk for MI began to be published in 1995, when Eriksson et al. [16] proved that subjects with coronary heart disease showed increased plasminogen-activator inhibitor 1 (PAI-1) activity, this being an independent risk factor for this disorder. The gene discussed is SERPINE1; the disease is coronary artery disorder.